Belite Bio (BLTE) Assets Average (2023 - 2025)
Belite Bio's quarterly Assets Average came in at $466.3 million in Q4 2025, up 277.95% year-on-year from $123.4 million in Q4 2024, and up 277.95% quarter-over-quarter from $123.4 million in Q4 2024.
Belite Bio has reported Assets Average for 4 years, with the latest figure at $466.3 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 277.95% year-over-year to $466.3 million; the trailing twelve-month figure through Dec 2025 stood at $466.3 million (up 277.95% YoY), and the FY2025 full-year result was $466.3 million, up 277.95% from the prior year.
- Assets Average for Q4 2025 stood at $466.3 million, up from $123.4 million in the prior quarter.
- The five-year high for Assets Average was $466.3 million in Q4 2025, with the low at $31.3 million in Q4 2022.
- Average Assets Average over 4 years is $172.6 million, with a median of $96.4 million recorded in 2023.
- Year-over-year, Assets Average jumped 77.64% in 2024 and jumped 277.95% in 2025.
- Tracing BLTE's Assets Average over 4 years: stood at $31.3 million in 2022, then jumped by 121.83% to $69.5 million in 2023, then jumped by 77.64% to $123.4 million in 2024, then jumped by 277.95% to $466.3 million in 2025.
- The last three Assets Average figures came in at $466.3 million (Q4 2025), $123.4 million (Q4 2024), and $69.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | 466.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 531.47 Mn |
| Sep 30, 2025 | 219.40 Mn |
| Jun 30, 2025 | 160.30 Mn |
| Mar 31, 2025 | 158.17 Mn |
| Dec 31, 2024 | 133.98 Mn |
| Sep 30, 2024 | 117.13 Mn |
| Jun 30, 2024 | 109.79 Mn |
| Mar 31, 2024 | 97.89 Mn |
| Dec 31, 2023 | 76.12 Mn |
| Sep 30, 2023 | 59.15 Mn |
| Jun 30, 2023 | 50.26 Mn |
| Mar 31, 2023 | 42.05 Mn |